Center for Biomolecular Structure Lecture Series

"N SILICO and STRUCTURE-GUIDED OF NOVRL ANTIVIRAL COMPOUNDS FOR HIV AND SARS COV-2 INFECTION"

Presented by Karen Anderson, Yale University

Wednesday, April 20, 2022, 1:30 pm — Videoconference / Virtual Event (see link below)

The primary aim of the Anderson Lab is the development of an in-depth mechanistic understanding of how enzymes function and thereby provide a more effective means of modulating their function by understanding enzymatic reactions and receptor-ligand interactions at the molecular level. Structure based drug design in conjunction with combinatorial library screening methods provide a powerful advance in identifying lead compounds. We are using this approach to examine the mechanisms HIV reverse transcriptase and SARS-CoV-2 main protease, as well as drug resistance which may ultimately aid in the design of better therapeutic agents.

Hosted by: Vivian Stojanoff

Videoconference Instructions

requires registration

Join Videoconference

17483  |  INT/EXT  |  Events Calendar